Detailansicht

Wissensnetz

Person

Oliver Philipp Wegehaupt (1987-)

Assistenzarzt

Name	Oliver Philipp Wegehaupt
Zeit	1987- (Lebensdaten)
Ort	München (Geburtsort) Deutschland
Akademischer Grad bzw. Titel	Dr. med.
Beruf	Assistenzarzt (charakteristischer Beruf)
Weitere Angaben	Diss. 2016, Universität Freiburg, Medizinische Fakultät
Datensatztyp	Person
GND-Nummer	1111900531
Datensatz-ID	1111900531
Beteiligt an alle anzeigen Variable Syndromic Immunodeficiency in Patients with Biallelic PRIM1 Mutations The role of the co‐chaperone DNAJB11 in polycystic kidney disease: molecular mechanisms and cellular origin of cyst formation Variable syndromic immunodeficiency in patients with Biallelic PRIM1 mutations Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature Disease progression of WHIM syndrome in an international cohort of 66 pediatric and adult patients Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient Agammaglobulinemia with normal B-cell numbers in a patient lacking Bob1 Ledipasvir/Sofosbuvir eradicates hepatitis C in an immunodeficient STAT3-GOF patient Cell versus cytokine – directed therapies for hemophagocytic lymphohistiocytosis (HLH) in inborn errors of immunity Ruxolitinib controls lymphoproliferation and Diabetes in a STAT3-GOF patient TIM‐3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis‐like T‐cell lymphoma and hemophagocytic lymphohistiocytosis BAG2, BAT3, DNAJB11, GNB2L1 und SERPINH1 interagieren in einem Netzwerk mit dem Polycystin-1-TRPP2-Signalmodul

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Oliver Philipp Wegehaupt (1987-)

Variable Syndromic Immunodeficiency in Patients with Biallelic PRIM1 Mutations

The role of the co‐chaperone DNAJB11 in polycystic kidney disease: molecular mechanisms and cellular origin of cyst formation

Variable syndromic immunodeficiency in patients with Biallelic PRIM1 mutations

Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature

Disease progression of WHIM syndrome in an international cohort of 66 pediatric and adult patients

Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient

Agammaglobulinemia with normal B-cell numbers in a patient lacking Bob1

Ledipasvir/Sofosbuvir eradicates hepatitis C in an immunodeficient STAT3-GOF patient

Cell versus cytokine – directed therapies for hemophagocytic lymphohistiocytosis (HLH) in inborn errors of immunity

Ruxolitinib controls lymphoproliferation and Diabetes in a STAT3-GOF patient

TIM‐3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis‐like T‐cell lymphoma and hemophagocytic lymphohistiocytosis

BAG2, BAT3, DNAJB11, GNB2L1 und SERPINH1 interagieren in einem Netzwerk mit dem Polycystin-1-TRPP2-Signalmodul